340B Drug Pricing Program
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin - December 16, 2025.
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
This webinar reviews key provisions proposed in the Outpatient, Ambulatory Surgical Center Final Rule for CY 2026. Some of the topics discussed include OPPS payment update and area wage index, Payment policies for drugs, biologicals and radiopharmaceuticals, Site-neutral payments, Behavioral health…
AHA 340B Advocacy Alliance - December 2, 2025.
AHA 340B Advocacy Alliance for December 1, 2025.
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District Court for the District of Maine to challenge the 340B Rebate Model Pilot Program.
Today, the American Hospital Association (AHA), the Maine Hospital Association (MHA) and four safety-net health systems from across the country filed a lawsuit in the United States District Court for the District of Maine to stop unlawful changes to a critical program that provides lower-cost drugs…
AHA 340B Advocacy Alliance for November 25, 2025.
AHA Board Chair Tina Freese Decker talks with AHA VP Aimee Kuhlman and Monument Health CEO Paulette Davidson about the benefits of the 340B program.